BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression to be Presented at the American Psychiatric Association Annual Meeting


4/5/2011 7:42:43 AM

SAN DIEGO, April 5, 2011 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that the Scientific Program Committee of the American Psychiatric Association has accepted for presentation their scientific and clinical report entitled, "Assessment of a Biomarker Panel for Major Depressive Disorder in a Community Based Study".

The presentation will be made by Dr. Perry Renshaw,Director of Magnetic Resonance, Utah Brain Institute, Professor of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT.

A blood test, for the first time, provides clinicians with biological information derived from physiological changes associated with MDD. By adding an objective, biological basis, the blood test results are intended to augment the current tools used for neuropsychiatric diagnosis and patient management.

"The data being presented a the APA meeting validates the clinical importance of the MDDScore in community-based psychiatric practices," stated Lonna J. Williams, CEO of Ridge Diagnostics. "The outcomes prove that accurate diagnosis can be difficult, even in psychiatric practices, and that patients both desire and respond to blood tests for mental health purposes as they are accustomed to blood tests for their medical care."

Dr. Renshaw will present the information at the APA Annual Meeting in Honolulu, HI, May 14-18, 2011.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The testing services are provided by the Ridge owned CLIA laboratory. The company is located in San Diego, CA and Research Triangle Park, NC. www.ridgedx.com

SOURCE Ridge Diagnostics, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->